EPI, a Missed Opportunity for Postpartum Family Planning Utilization

Contraception Clinical Trial

— EPI  

Official title:

Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization: A Quasi Experimental Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04767139
• Other study ID #: g6t4n7gi
• Status: Completed
• Start date: February 1, 2020
• Est. completion date: October 28, 2022

Study information

• Verified date: March 2023
• Source: Hawassa University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The global unmet need for postpartum family planning remains high, while immunization services are among the most widely utilized health services. Most women in the extended postpartum period want to delay or avoid future pregnancies but many are not using a modern contraceptive method. Establishing systematic screening, counseling, and referral systems from different contact points particularly from infant immunization units may improve family planning access and uptake in the extended postpartum period. Hence, this study is aimed to assess the effect of counseling for family planning at immunization units on postpartum contraceptive uptake during the extended postpartum period.

Description:

Background: The global unmet need for postpartum family planning remains high, while immunization services are among the most widely utilized health services. Most women in the extended postpartum period want to delay or avoid future pregnancies but many are not using a modern contraceptive method. Establishing systematic screening, counseling, and referral systems from different contact points particularly from Expanded Program for Immunization (EPI) units may improve family planning access and uptake in the extended perinatal period. Therefore, this study is proposed to assess the effect of counseling for family planning at immunization units on postpartum contraceptive uptake during the extended postpartum period. To do this, a before-and-after type of quasi-experimental study will be conducted in purposively selected health centers in Sidama, South Ethiopia. All mothers coming to the selected health centers for infant immunization services will be screened for, counseled, and referred for family planning. A structured interviewer-administered questionnaire will be used to collect quantitative data from a total of 1474 randomly selected women coming to purposively selected health centers before and after the intervention. Bivariate and multivariable logistic regression analysis adjusting for possible confounding variables will be computed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1474
• Est. completion date: October 28, 2022
• Est. primary completion date: February 25, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 15 Years to 49 Years

Eligibility

Inclusion Criteria:

• all women visiting the selected health facilities at least two times during the pre-intervention period will be included

Exclusion Criteria:

• No exclussion critera

Related Conditions & MeSH terms

• Contraception

Intervention

Behavioral:
• counseling for family planning
all mothers presented to infant immunization units of the selected health centers will be counseled for family planning service and referred to the family planning unit if they decided to use.

Locations

Country	Name	City	State
Ethiopia	Sidama regional health bureau	Hawassa	Sidama

Sponsors (2)

Lead Sponsor	Collaborator
Hawassa University	EngenderHealth

Country where clinical trial is conducted

Ethiopia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	improved contraceptive uptake	the contraceptive utilization rate will be increased after the initiation of the intervention	March 3, 2021